Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES LUPIN ALKEM LABORATORIES/
LUPIN
 
P/E (TTM) x 29.5 -14.4 - View Chart
P/BV x 4.5 2.6 176.2% View Chart
Dividend Yield % 1.0 0.6 176.1%  

Financials

 ALKEM LABORATORIES   LUPIN
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
LUPIN
Mar-22
ALKEM LABORATORIES/
LUPIN
5-Yr Chart
Click to enlarge
High Rs4,0681,268 320.9%   
Low Rs2,671679 393.6%   
Sales per share (Unadj.) Rs889.4361.0 246.4%  
Earnings per share (Unadj.) Rs140.5-33.2 -423.0%  
Cash flow per share (Unadj.) Rs166.03.3 5,062.2%  
Dividends per share (Unadj.) Rs34.004.00 850.0%  
Avg Dividend yield %1.00.4 245.5%  
Book value per share (Unadj.) Rs722.4263.9 273.8%  
Shares outstanding (eoy) m119.57454.48 26.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.82.7 140.5%   
Avg P/E ratio x24.0-29.3 -81.8%  
P/CF ratio (eoy) x20.3296.8 6.8%  
Price / Book Value ratio x4.73.7 126.5%  
Dividend payout %24.2-12.0 -200.9%   
Avg Mkt Cap Rs m402,868442,238 91.1%   
No. of employees `000NANA-   
Total wages/salary Rs m19,62729,893 65.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,342164,055 64.8%  
Other income Rs m1,6272,137 76.1%   
Total revenues Rs m107,968166,192 65.0%   
Gross profit Rs m20,3802,152 946.8%  
Depreciation Rs m3,04016,587 18.3%   
Interest Rs m5241,428 36.7%   
Profit before tax Rs m18,443-13,726 -134.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6401,372 119.5%   
Profit after tax Rs m16,803-15,097 -111.3%  
Gross profit margin %19.21.3 1,460.7%  
Effective tax rate %8.9-10.0 -89.0%   
Net profit margin %15.8-9.2 -171.7%  
BALANCE SHEET DATA
Current assets Rs m84,354124,577 67.7%   
Current liabilities Rs m48,05382,764 58.1%   
Net working cap to sales %34.125.5 133.9%  
Current ratio x1.81.5 116.6%  
Inventory Days Days4233 126.7%  
Debtors Days Days6595 68.2%  
Net fixed assets Rs m43,24591,938 47.0%   
Share capital Rs m239909 26.3%   
"Free" reserves Rs m86,134119,006 72.4%   
Net worth Rs m86,373119,915 72.0%   
Long term debt Rs m941,419 6.6%   
Total assets Rs m127,599216,515 58.9%  
Interest coverage x36.2-8.6 -420.4%   
Debt to equity ratio x00 9.2%  
Sales to assets ratio x0.80.8 110.0%   
Return on assets %13.6-6.3 -215.1%  
Return on equity %19.5-12.6 -154.5%  
Return on capital %21.9-10.1 -216.4%  
Exports to sales %18.70-   
Imports to sales %00-   
Exports (fob) Rs m19,924NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,92453,594 37.2%   
Fx outflow Rs m3,91138,143 10.3%   
Net fx Rs m16,01315,451 103.6%   
CASH FLOW
From Operations Rs m11,1103,673 302.5%  
From Investments Rs m-14,35112,922 -111.1%  
From Financial Activity Rs m3,796-15,723 -24.1%  
Net Cashflow Rs m580872 66.5%  

Share Holding

Indian Promoters % 57.1 46.8 122.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 19.8 41.5 47.7%  
FIIs % 5.7 14.3 39.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 52.9 81.0%  
Shareholders   84,104 382,828 22.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    


More on ALKEM LABORATORIES vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Lupin Share Price Performance

Period ALKEM LABORATORIES Lupin S&P BSE HEALTHCARE
1-Day 0.81% 3.91% 0.67%
1-Month 10.23% 1.57% 1.42%
1-Year -17.60% -28.54% -10.55%
3-Year CAGR 19.88% -1.69% 23.16%
5-Year CAGR 12.25% -7.81% 11.48%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.1% stake in the company. In case of Lupin the stake stands at 47.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at -12.0%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

3 Reasons Why Sensex Rallied 1,016 Points Today(Closing)

After opening the day on a strong note, Indian share markets extended gains as the session progressed and ended near day's high.